Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN Trials

STUDY OBJECTIVE: Telavancin and vancomycin are both approved for treatment of hospital‐acquired and ventilator‐associated bacterial pneumonias caused by Staphylococcus aureus, and both agents can cause renal dysfunction. The objective of this study was to assess renal function changes by performing...

Descripción completa

Detalles Bibliográficos
Autores principales: Nogid, Boris, Lacy, Melinda K., Jacobs, Micah, Bruss, Jon, Dwyer, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221095/
https://www.ncbi.nlm.nih.gov/pubmed/30003567
http://dx.doi.org/10.1002/phar.2165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221095/
https://www.ncbi.nlm.nih.gov/pubmed/30003567
http://dx.doi.org/10.1002/phar.2165

Ejemplares similares